Parliamentary Search

Written question asked by Dan Carden (Labour) on Friday, 9 May 2025, in the House of Commons. It was due for an answer on Tuesday, 13 May 2025. It was answered by Stephen Kinnock (Labour) on Thursday, 15 May 2025 on behalf of the Department of Health and Social Care.

Paediatric Autoimmune Neuropsychiatric Disorders

Question

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve (a) diagnosis and (b) treatment for Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections.

Answer

The Department recognises the importance of raising awareness of conditions such as paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorder associated with streptococcus (PANDAS) among healthcare professionals, and improving the health and care system for the people living with them.

The National Institute for Health and Care Excellence (NICE) is the independent, expert body that develops evidence-based guidelines for the National Health Service on best practice. While the NICE currently has no plans to issue guidance on PANS and PANDAS, should the evidence base develop further, we would look to the NICE to update clinical policy.

In the meantime, integrated care systems are responsible for planning care for their populations’ conditions, and clinicians will want to take account of any new research and developments in guidance, such as those being overseen by the PANS PANDAS Steering Group, to ensure that they can continue to provide high quality care to their patients.

Secondary information

Type
Written question
Reference
51140
Session
2024-26
Subjects
Diagnosis Health services Paediatric autoimmune neuropsychiatric disorders Streptococcus
Link
View this Written question on www.parliament.uk